Joseph E. Payne - Dec 15, 2023 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
President and CEO, Director
Signature
/s/ Ilan Katz, attorney-in-fact
Stock symbol
ARCT
Transactions as of
Dec 15, 2023
Transactions value $
$0
Form type
4
Date filed
12/19/2023, 08:00 PM
Previous filing
Dec 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Employee Stock Option (right to buy) Award $0 +200K $0.00 200K Dec 15, 2023 Common Stock 200K $28.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2 The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.